Tilsotolimod sodium

Tilsotolimod sodium is a synthetic TLR9 agonist that has demonstrated antitumor efficacy in preclinical studies. It is used in research to investigate immunostimulatory pathways, with applications in both in vitro immune cell activation assays and in vivo tumor model experiments.